Use of granulocyte colony-stimulating factor: A survey among Italian medical oncologists

Oncology Reports

Volumn 14, Issue 6, 2005, Pages 1405-1412

  Danova, Marco ^a   Rosti, Giovanni ^b   De Placido, Sabino ^c   Bencardino, Katia ^a   Venturini, Marco ^d  

^a FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^b SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

Granulocyte colonystimulating factor; Growth factors; Guidelines; Neutropenia

Indexed keywords

GRANULOCYTE COLONY STIMULATING FACTOR;

ARTICLE; CLINICAL PRACTICE; HUMAN; INFORMATION PROCESSING; ITALY; NEUTROPENIA; ONCOLOGY; ORGANIZATION AND MANAGEMENT; PRACTICE GUIDELINE; STATISTICS;

DATA COLLECTION; GRANULOCYTE COLONY-STIMULATING FACTOR; GUIDELINE ADHERENCE; HUMANS; ITALY; MEDICAL ONCOLOGY; NEUTROPENIA; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 33644670992     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.14.6.1405     Document Type: Article

References (9)

1. Dale D: Current management of chemotherapy-induced neutropenia: the role of colony-stimulating factors. Sem Oncol 30: 3-9, 2003.
2. American Society of Clinical Oncology: Recommendations for the use of hematopoietic growth factors: Evidence based clinical practice guidelines. J Clin Oncol 12: 2471-2508, 1994.
3. Ozer H, Armitage JO, Bennett CL, Crawford J, Demetri GD, Pizzo PA, Schiffer CA, Smith TJ, Somlo G, Wade JC, Wade JL, Winn RJ, Wozniak AJ, and Somerfield MR for the American Society of Clinical Oncology Growth Factors Expert Panel: 2000 Updated of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 18: 3558-3585, 2000.
4. Bennett CL, Smith TJ, Weeks JC, Bredt AB, Feinglass J, Fetting JH, Hillner BE, Somerfield MR and Winn RJ: Use of hematopoietic colony-stimulating factors: the American Society of Clinical Oncology survey. J Clin Oncol 14: 2511-2520,1996. (Pubitemid 26300118)
5. Bennett CL, Weeks JA, Somerfield MR, Feinglass J and Smith TJ: Use of hematopoietic colony-stimulating factors: comparison of the 1994 and 1997 American Society of Clinical Oncology surveys regarding ASCO clinical practice guidelines. J Clin Oncol 17: 3676-3681, 1999. (Pubitemid 29517939)
6. AIOM: Guidelines about the use of haematopoietic colony-stimulating factors. http://www.aiom.it/doc/pdf/FattoriEmatopoietici.pdf.
7. Lyman GH: Balancing the benefits and costs of colony-stimulating factors: a current perspective. Sem Oncol 30: 10-17, 2003.
8. Lyman GH: A predictive model for neutropenia associated with cancer chemotherapy. Pharmacotherapy 20: 104S-111S, 2000.
9. Crawford S: Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia. Sem Oncol 4:24-30,2003.